|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer显示文摘 | Moussa O Yordy JS Abol-Enein H | 2005 | Cancer Res2005，65，11： | 1 |
| 2 | Signal transduction and the Ets family of transcription factors显示文摘 | Muise-Helmericks RC | 2000 | Oncogene2000，19，55： | 1 |
| 3 | DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death fallowing radiotherapy 显示文摘 | Moeller B J Yordy JS Williams MD | 2011 | Clin Cancer Res2011，17，： | 1 |
| 4 | DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts lo coregional failure and death following radiotherapy ]显示文摘 | Moeller BJ Yordy JS Williams MD | 2011 | Clin Cancer Res2011，17，7： | 1 |
| 5 | Phase Ⅱ trial of eetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression显示文摘 | Crane CH Varadhachary GR Yordy JS | 2011 | J Clin Oncol2011，29，22： | 1 |
| 6 | SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion 显示文摘 | Yordy JS Li R Sementchenko VI | 2004 | Oncogene2004，23，39： | 1 |
| 7 | Phase II trial of cetux- imah, gemdtabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocardnoma: Corre- lation of Smad4(Dpc4) immunostaining with pattern of disease progres- sion显示文摘 | Crane CH Varadhachary GR Yordy JS | 2011 | J Clin Oncol2011，29，22： | 1 |
| 8 | SP100 inhibits ETS1 activity in primary endothelial cells显示文摘 | Yordy JS Moussa O Pei H | 2005 | Oncogene2005，24，5： | 1 |
| 9 | Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced(T4) Pancreatic Adenocarcinoma: Correlation of Smad4 (Dpe4) Immunostaining With Pattern of Disease Progression 显示文摘 | Crane CH Varadhachary GR Yordy JS | 2011 | J Clin OncoJ2011，29，22： | 1 |
| 10 | Prognostic and Func- tional Significance of Thromboxane Synthase Gene Overexpression in Invasive Bladder Cancer显示文摘 | Moussa O Yordy JS Abol - Enein H | 2005 | Cancer Res2005，65，11： | 1 |
| 11 | Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradi- ation with cetuximab for locally advanced (T4) pancreatic adeno- carcinoma: correlation of Smad4 (Dpc4) immunostaining with pat- tern of disease progression显示文摘 | Crane CH Varadhachary GR Yordy JS | 2011 | J Clin Oncol2011，29，22： | 1 |
| 12 | Signal transduction and the Ets family of transcription factors 显示文摘 | Yordy JS Muise-Helmericks RC | 2000 | Oncogene2000，19，55： | 1 |
| 13 | Phase IT trail of ee- tuximab,gemcitabine, and oxaliplatin followed by ehemoradiation with cetuximab for locally advanced (T4)panereatic adenocarcino- ma:Correlation of smad4 (Dpc4)immunostaining with pattern of dis- ease progression 显示文摘 | Crane CH Varadhaehary GR Yordy JS | 2011 | J Clin Oncol2011，29，22： | 1 |
| 14 | Signal transduction and Ets family of transcription factors 显示文摘 | Yordy JS Muise-Hemericks RC | 2000 | Oncongene2000，19，55： | 1 |
| 15 | DNA repair biomarker profiling of head and neck cancer:Ku80 expression predicts locoregional failure and death following radiotherapy显示文摘 | Moeller BJ Yordy JS Williams MD | | 0，，7： | 1 |
| 16 | Signal transduction and the Ets family of transcription factors 显示文摘 | Yordy JS Muise Helmericks RC | 2000 | Oncogene2000，19，55： | 1 |
| 17 | SP100 expression modu- lates ETS1 transcriptional activity and inhibits cell invasion 显示文摘 | Yordy JS Li R Sementchenko VI | 2004 | Oncogene2004，23，39： | 1 |
| 18 | DNA repair biomarker profiling of head and neck cancer:Ku80 expression predicts locoregional failure and death following radiotherapy显示文摘 | Moeller BJ Yordy JS Williams MD | | 0，，07： | 1 |
| 19 | EAPⅡ interacts with ETS1 and modulates its transcriptional function显示文摘 | Pei H Yordy JS Leng Q | 2003 | Oncogene2003，22，5： | 1 |
| 20 | SP100 inhibits ETS1 activity in primary endothelial cells 显示文摘 | Yordy JS Moussa O Pei H | 2005 | Oncogene2005，24，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员